Aileron Therapeutics (NASDAQ:ALRN – Get Rating) is scheduled to announce its earnings results on Wednesday, May 3rd. Aileron Therapeutics Stock Performance ALRN stock traded down $0.05 during trading on Tuesday, hitting $1.40. 4,918 shares of the company’s stock traded hands, compared to its average volume of 48,079. Aileron Therapeutics has a 52 week low of […]
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decrease of 27.6% from the March 31st total of 35,500 shares. Based on an average daily volume of 52,100 shares, the days-to-cover ratio is […]
Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decline of 27.6% from the March 31st total of 35,500 shares. Based on an average trading volume of 52,100 shares, the short-interest ratio is […]
Aileron Therapeutics (NASDAQ:ALRN – Get Rating) and Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, risk, dividends and valuation. Analyst Ratings This is a summary of current ratings […]